Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II

MGMT promotor methylation is associated with favourable outcome in high-grade glioma. In glioma WHO grade II, it is unclear whether the extent of MGMT promotor methylation and its prognostic role is independent from other molecular markers. We performed a retrospective analysis of 155 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Karschnia, Philipp, Teske, Nico, Dorostkar, Mario M., Siller, Sebastian, Weller, Jonathan, Baehring, Joachim M., Dietrich, Jorg, von Baumgarten, Louisa, Herms, Jochen, Tonn, Joerg-Christian, Thon, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661705/
https://www.ncbi.nlm.nih.gov/pubmed/33184319
http://dx.doi.org/10.1038/s41598-020-76312-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661705/
https://www.ncbi.nlm.nih.gov/pubmed/33184319
http://dx.doi.org/10.1038/s41598-020-76312-x

Ejemplares similares